Triple-negative breast cancer—current status and future directions
作者： O. Gluz , C. Liedtke , N. Gottschalk , L. Pusztai , U. Nitz
关键词:
摘要: … Also, a subgroup of TNBC shows resistance to taxane–anthracycline-containing chemotherapy despite high grade [98] indicating that some TNBCs carry additional molecular features …
annalsofoncology.org
oup.com
oxfordjournals.org
paperity.org参考文章(162)
JA Sparano, R Gray, LJ Goldstein, BH Childs, R Bugarini, S Rowley, J Baker, S Shak, S Badve, FL Baehner, EA Perez, LN Shulman, S Martino, GW Sledge Jr., NE Davidson, GRB7-dependent pathways are potential therapeutic targets in triple-negative breast cancer. Cancer Research. ,vol. 69, pp. 25- ,(2009) , 10.1158/0008-5472.SABCS-25
Susan Cleator, Wolfgang Heller, R Charles Coombes, Triple-negative breast cancer: therapeutic options Lancet Oncology. ,vol. 8, pp. 235- 244 ,(2007) , 10.1016/S1470-2045(07)70074-8
C. Chabalier, C. Lamare, C. Racca, M. Privat, A. Valette, F. Larminat, BRCA1 Downregulation Leads to Premature Inactivation of Spindle Checkpoint and Confers Paclitaxel Resistance Cell Cycle. ,vol. 5, pp. 1001- 1007 ,(2006) , 10.4161/CC.5.9.2726
Daniel F Hayes, Ann D Thor, Lynn G Dressler, Donald Weaver, Susan Edgerton, David Cowan, Gloria Broadwater, Lori J Goldstein, Silvana Martino, James N Ingle, I Craig Henderson, Larry Norton, Eric P Winer, Clifford A Hudis, Matthew J Ellis, Donald A Berry, HER2 and Response to Paclitaxel in Node-Positive Breast Cancer The New England Journal of Medicine. ,vol. 357, pp. 1496- 1506 ,(2007) , 10.1056/NEJMOA071167
J Tommiska, J Bartkova, M Heinonen, L Hautala, O Kilpivaara, H Eerola, K Aittomäki, B Hofstetter, J Lukas, K von Smitten, C Blomqvist, A Ristimäki, P Heikkilä, J Bartek, H Nevanlinna, The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer. Oncogene. ,vol. 27, pp. 2501- 2506 ,(2008) , 10.1038/SJ.ONC.1210885
William D. Foulkes, Ian E. Smith, Jorge S. Reis-Filho, Triple-negative breast cancer. The New England Journal of Medicine. ,vol. 363, pp. 1938- 1948 ,(2010) , 10.1056/NEJMRA1001389
W. Fraser Symmans, Florentia Peintinger, Christos Hatzis, Radhika Rajan, Henry Kuerer, Vicente Valero, Lina Assad, Anna Poniecka, Bryan Hennessy, Marjorie Green, Aman U. Buzdar, S. Eva Singletary, Gabriel N. Hortobagyi, Lajos Pusztai, Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy Journal of Clinical Oncology. ,vol. 25, pp. 4414- 4422 ,(2007) , 10.1200/JCO.2007.10.6823
Charles M. Perou, Therese Sørlie, Michael B. Eisen, Matt van de Rijn, Stefanie S. Jeffrey, Christian A. Rees, Jonathan R. Pollack, Douglas T. Ross, Hilde Johnsen, Lars A. Akslen, Øystein Fluge, Alexander Pergamenschikov, Cheryl Williams, Shirley X. Zhu, Per E. Lønning, Anne-Lise Børresen-Dale, Patrick O. Brown, David Botstein, Molecular portraits of human breast tumours Nature. ,vol. 406, pp. 747- 752 ,(2000) , 10.1038/35021093
Torsten O Nielsen, Forrest D Hsu, Kristin Jensen, Maggie Cheang, Gamze Karaca, Zhiyuan Hu, Tina Hernandez-Boussard, Chad Livasy, Dave Cowan, Lynn Dressler, Lars A Akslen, Joseph Ragaz, Allen M Gown, C Blake Gilks, Matt van de Rijn, Charles M Perou, None, Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma Clinical Cancer Research. ,vol. 10, pp. 5367- 5374 ,(2004) , 10.1158/1078-0432.CCR-04-0220
Takayoshi Uematsu, Masako Kasami, Sachiko Yuen, Triple-Negative Breast Cancer: Correlation between MR Imaging and Pathologic Findings Radiology. ,vol. 250, pp. 638- 647 ,(2009) , 10.1148/RADIOL.2503081054